Glucocorticoid receptor repression mediated by BRCA1 inactivation in ovarian cancer

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Fang, Yuan Yuan ^a   Li, Da ^a   Cao, Chen ^b   Li, Chun Yan ^c   Li, Ting Ting ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

BRCA1; BRCA2; Glucocorticoid receptor; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN; DNA; GLUCOCORTICOID RECEPTOR; LENTIVIRUS VECTOR;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE REPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OVARY CANCER; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; GENE MUTATION; HEK293 CELL LINE; HUMAN CELL; HUMAN TISSUE; OVARIAN CANCER CELL LINE;

BRCA1 PROTEIN; BRCA2 PROTEIN; CHROMOSOMES, HUMAN, PAIR 17; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC; RECEPTORS, GLUCOCORTICOID; TUMOR CELLS, CULTURED;

EID: 84899144856     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-188     Document Type: Article

References (22)

1. Kim A, Ueda Y, Naka T, Enomoto T. Therapeutic strategies in epithelial ovarian cancer. J Exp Clin Cancer Res 2012, 31:14. 10.1186/1756-9966-31-14, 3309949, 22330607.
2. Pruthi S, Gostout BS, Lindor NM. Identification and management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer. Mayo Clin Proc 2010, 85:1111-1120. 10.4065/mcp.2010.0414, 2996153, 21123638.
3. Werner H, Bruchim I. IGF-1 and BRCA1 signalling pathways in familial cancer. Lancet Oncol 2012, 13:e537-544. 10.1016/S1470-2045(12)70362-5, 23182194.
4. Ramamoorthy S, Cidlowski JA. Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance. Endocr Dev 2013, 24:41-56.
5. Chen YX, Wang Y, Fu CC, Diao F, Song LN, Li ZB, Yang R, Lu J. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells. Endocr Relat Cancer 2010, 17:39-50. 10.1677/ERC-08-0296, 19776289.
6. Melhem A, Yamada SD, Fleming GF, Delgado B, Brickley DR, Wu W, Kocherginsky M, Conzen SD. Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues. Clin Cancer Res 2009, 15:3196-3204. 10.1158/1078-0432.CCR-08-2131, 19383827.
7. Dickinson RE, Fegan KS, Ren X, Hillier SG, Duncan WC. Glucocorticoid regulation of SLIT/ROBO tumour suppressor genes in the ovarian surface epithelium and ovarian cancer cells. PLoS One 2011, 6:e27792. 10.1371/journal.pone.0027792, 3223191, 22132142.
8. Silverman MN, Sternberg EM. Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci 2012, 1261:55-63. 10.1111/j.1749-6632.2012.06633.x, 3572859, 22823394.
9. Vilasco M, Communal L, Hugon-Rodin J, Penault-Llorca F, Mourra N, Wu Z, Forgez P, Gompel A., Bracaps Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. Breast Cancer Res Treat 2013, 142:283-296. 10.1007/s10549-013-2722-8, 24166279, Bracaps.
10. Luo M, Lu X, Zhu R, Zhang Z, Chow CC, Li R, Simons SS. A conserved protein motif is required for full modulatory activity of negative elongation factor subunits NELF-A and NELF-B in modifying glucocorticoid receptor-regulated gene induction properties. J Biol Chem 2013, 288:34055-34072. 10.1074/jbc.M113.512426, 24097989.
11. Bi FF, Li D, Yang Q. Promoter hypomethylation, especially around the E26 transformation-specific motif, and increased expression of poly (ADP-ribose) polymerase 1 in BRCA-mutated serous ovarian cancer. BMC Cancer 2013, 13:90. 10.1186/1471-2407-13-90, 3599366, 23442605.
12. Szlosarek PW, Grimshaw MJ, Kulbe H, Wilson JL, Wilbanks GD, Burke F, Balkwill FR. Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium. Mol Cancer Ther 2006, 5:382-390. 10.1158/1535-7163.MCT-05-0303, 16505113.
13. Suvà ML, Riggi N, Bernstein BE. Epigenetic reprogramming in cancer. Science 2013, 339:1567-1570. 10.1126/science.1230184, 3821556, 23539597.
14. Li D, Bi FF, Cao JM, Cao C, Li CY, Yang Q. Effect of BRCA1 on epidermal growth factor receptor in ovarian cancer. J Exp Clin Cancer Res 2013, 32:102. 10.1186/1756-9966-32-102, 24321281.
15. Calvo V, Beato M. BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. Cancer Res 2011, 71:3422-3431. 10.1158/0008-5472.CAN-10-3670, 21531767.
16. Ma Y, Fan S, Hu C, Meng Q, Fuqua SA, Pestell RG, Tomita YA, Rosen EM. BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha. Mol Endocrinol 2010, 24:76-90. 10.1210/me.2009-0218, 2802901, 19887647.
17. Burga LN, Tung NM, Troyan SL, Bostina M, Konstantinopoulos PA, Fountzilas H, Spentzos D, Miron A, Yassin YA, Lee BT, Wulf GM. Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers. Cancer Res 2009, 69:1273-1278. 10.1158/0008-5472.CAN-08-2954, 3041511, 19190334.
18. Promkan M, Liu G, Patmasiriwat P, Chakrabarty S. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells. Int J Cancer 2009, 125:2820-2828. 10.1002/ijc.24684, 19551867.
19. Kang HJ, Yi YW, Kim HJ, Hong YB, Seong YS, Bae I. BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site. Cell Death Dis 2012, 3:e336. 10.1038/cddis.2012.78, 3388245, 22739988.
20. Wen J, Li R, Lu Y, Shupnik MA. Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions. Oncogene 2009, 28:575-586. 10.1038/onc.2008.405, 2714665, 18997820.
21. Katiyar P, Ma Y, Riegel A, Fan S, Rosen EM. Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity. Mol Endocrinol 2009, 23:1135-1146. 10.1210/me.2008-0347, 2718743, 19389812.
22. Lu J. The anti-proliferation mechanism of glucocorticoid mediated by glucocorticoid receptor-regulating gene expression. Pathophysiology 2009, 16:267-272. 10.1016/j.pathophys.2009.02.009, 19278840.